Fundraising FoxFuture Ventures — 2022 Investments
6 investments dated 2022 · listed companies and verified rows first · show all
64x provides a platform and product suite for manufacturing advanced therapeutics, including gene therapies, cell therapies, and biologics.
BiotechDeep TechMedical Devices
Co-investorsBoxGroupFirst Round CapitalFifty YearsLifeforce CapitalNorthpond VenturesRefactor Capital+1 more
64x develops infrastructure and manufacturing systems for next-generation medicines, focusing on genetic engineering, cell line development, and computational biology to enable scalability of advanced therapies.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Lexi Rovner(CEO, Co-founder, Board of Directors)inAlexis Rovner(Founder)Ryan GallagherEmily Hawkins(Head of Talent)George Church, PhD(Co-founder, Scientific Advisory Board)David Thompson, PhD(Co-founder, Scientific Advisory Board)
Co-investorsFifty YearsG VenturesLifeforce CapitalRaptor GroupY CombinatorAlix Ventures+8 more
Osmind is a public benefit corporation developing technology and research infrastructure to accelerate evidence-based mental health treatments, including therapies like ketamine, and to improve patient access to care.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesMental HealthSaaSSan Francisco, US
Lucia Huang(Founder)inJimmy Qian(Founder)inJacob Anstey(Operations Associate)Sam Kennedy(Head of Engineering)Rachel Rosenberg(Customer Operations Lead)Mapolo Buessing(Product Manager)
Co-investorsAble PartnersFelicis VenturesGaingelsGeneral CatalystGold House VenturesMVP Ventures+16 more
__Twitter.png)
.png)
ShennonBio develops immunotherapy technologies using microfluidic engineering, computational biology, and immunology to advance T cell engineering for cancer treatment.
AI & Machine LearningBiotechDeep TechMedical DevicesSan Francisco, US
Li Sun, PhD(Founder/CEO)in
BoardJAMES HARDIMAN(Director)in
Co-investorsAV8 VenturesDCVC (Data Collective)Foundation CapitalNextGen Venture PartnersSamos Investments
Verdant is a software platform that manages the full planning and permitting workflow for local government agencies, from resident inquiries through final commission votes.
AI & Machine LearningGovTechSan Francisco, US
Aidan Ng(Founder)inJason Yi(Founder)in
Co-investorsY CombinatorAgFunderAutotech VenturesCavallo VenturesCleveland AvenueDCVC Bio+4 more
YourChoice Therapeutics develops YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials that works by blocking a receptor essential for sperm production.
BiotechHealthtechMedical DevicesSan Francisco, US
Akash Bakshi(CEO)inNadja Mannowetz(Founder)inAndrew Bartynski(COO)Polina Lishko
Co-investorsBlue Bear VenturesForeground CapitalOlive Tree CapitalPortfoliaY Combinator8VC+11 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.